These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 38617532)
1. CYSLTR1 antagonist inhibits Th17 cell differentiation by regulating the NF-κB signaling for the treatment of psoriasis. Zhao J; Chen Y; Li L; Yin H; Song S; Wang Y; Feng X; Fan X; Gao C; Gao L; Zhan Y; Zhao M; Li X; Lu Q Int J Biol Sci; 2024; 20(6):2168-2186. PubMed ID: 38617532 [TBL] [Abstract][Full Text] [Related]
2. Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model. Han B; Zhang YY; Ye ZQ; Xiao Y; Rasouli J; Wu WC; Ye SM; Guo XY; Zhu L; Rostami A; Wang LB; Zhang Y; Li X Immunology; 2021 Jun; 163(2):185-200. PubMed ID: 33480040 [TBL] [Abstract][Full Text] [Related]
3. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
4. Montelukast attenuates interleukin IL-1β-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2). Li Z; Wang J; Ma Y Bioengineered; 2021 Dec; 12(1):8476-8484. PubMed ID: 34565285 [TBL] [Abstract][Full Text] [Related]
5. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840 [TBL] [Abstract][Full Text] [Related]
6. Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689 [TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model. Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414 [TBL] [Abstract][Full Text] [Related]
9. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway. Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632 [TBL] [Abstract][Full Text] [Related]
10. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways. Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480 [TBL] [Abstract][Full Text] [Related]
11. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569 [TBL] [Abstract][Full Text] [Related]
12. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation. Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123 [TBL] [Abstract][Full Text] [Related]
13. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice. Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383 [TBL] [Abstract][Full Text] [Related]
14. [Effect and mechanism of Maxing Shigan Decoction on reducing inflammatory response in rats with cough variant asthma via TLR4/MyD88/NF-κB and p38 MAPK signaling pathways]. Fu ZH; Zhou L; Nie AZ Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1000-1006. PubMed ID: 38621907 [TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion. Zhao J; Di T; Wang Y; Wang Y; Liu X; Liang D; Li P Eur J Pharmacol; 2016 Feb; 772():131-43. PubMed ID: 26738780 [TBL] [Abstract][Full Text] [Related]
16. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-κB/MAPK/Nrf2 pathways. Xiong Y; Wang J; Wang S; Li H; Zhou X J Nat Med; 2023 Jan; 77(1):188-201. PubMed ID: 36378401 [TBL] [Abstract][Full Text] [Related]
17. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways. Guo H; Li M; Liu H Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231 [TBL] [Abstract][Full Text] [Related]
18. Deciphering the mechanism of Fang-Ji-Di-Huang-Decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23/Th17 cell axis. Song C; Yang C; Meng S; Li M; Wang X; Zhu Y; Kong L; Lv W; Qiao H; Sun Y J Ethnopharmacol; 2021 Dec; 281():114571. PubMed ID: 34464701 [TBL] [Abstract][Full Text] [Related]
19. Khasianine ameliorates psoriasis-like skin inflammation and represses TNF-α/NF-κB axis mediated transactivation of IL-17A and IL-33 in keratinocytes. Yang Y; Zhang Y; Chen X; Su Z; Deng Y; Zhao Q J Ethnopharmacol; 2022 Jun; 292():115124. PubMed ID: 35183690 [TBL] [Abstract][Full Text] [Related]
20. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation. Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]